- Medical news & Guidelines
- Cardiology and CTVS
- Critical Care
- Diabetes and Endocrinology
- Laboratory Medicine
- Health news
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Dadra and Nagar Haveli
- Daman and Diu
- Himachal Pradesh
- Jammu & Kashmir
- Madhya Pradesh
- Tamil Nadu
- Uttar Pradesh
- West Bengal
- Medical Education
Cipla arm's oral liquid dosage, nasal product unit acquired by Rubicon Research
New Delhi: Specialty pharma firm Rubicon Research on Friday said it has acquired Meditab Specialities'' oral liquid dosage and nasal product manufacturing facility at Satara in Maharashtra.Meditab Specialities is a wholly-owned subsidiary of Cipla.Without disclosing the deal size, Rubicon Research said the Satara facility is cGMP compliant and MHRA (UK)-inspected production site.The...
New Delhi: Specialty pharma firm Rubicon Research on Friday said it has acquired Meditab Specialities'' oral liquid dosage and nasal product manufacturing facility at Satara in Maharashtra.
Meditab Specialities is a wholly-owned subsidiary of Cipla.
Without disclosing the deal size, Rubicon Research said the Satara facility is cGMP compliant and MHRA (UK)-inspected production site.
The facility enables a strong and diverse pipeline of oral liquids for Rubicon Research, it said in a statement.
The company will seek additional regulatory approvals for the Satara site, including from the United States Food and Drug Administration (USFDA), it added.
Read also: MSD in talks with 5 Indian drugmakers for clinical trial of COVID drug Molnupiravir
"The acquisition of an outstanding oral liquid and nasal inhalers manufacturing facility advances our plan to offer a wider portfolio to our customers," Rubicon Research CEO Parag Sancheti said.
These capabilities combined with Rubicon''s research and development expertise strengthens the company''s ability to offer best-in-class drug products across dosage forms, he added
Read also: Cipla gets DCGI nod to import Moderna COVID vaccine
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at email@example.com Contact no. 011-43720751